Fluxion Biosciences was founded in 2005 in San Francisco, California in the USA with its principal focus on analytical instruments for functional cellular analyses. In 2008, BioFlux 200 was the recipient of the R&D 100 Award given by R&D Magazine to the top 100 new technologies of the year. In 2010 and 2013, Fluxion received additional R&D 100 awards for the IonFlux HT System and IsoFlux System, respectively. In addition to its core product lines, Fluxion is also engaged in cutting-edge research to produce the next generation of breakthrough technologies.

Liquid Biopsy Tools
  • IsoFlux System, for CTC enrichment and recovery
  • CTC and cfDNA Assays for ultra-sensitive mutation detection
  • Somatic Mutation Detection from Liquid Biopsies
Close Menu